Alzamend Neuro Partners with Massachusetts General Hospital for a Phase II Clinical Trial of AL001, a Next?Generation Lithium Therapeutic Drug Candidate, involving Patients with Bipolar Disorder

Stock Information for Alzamend Neuro Inc.

Loading

Please wait while we load your information from QuoteMedia.